CompletedNot Applicable

Clinical Outcomes and Healthcare Economics of SOLTIVE Compared to Ho:YAG Laser in Urolithiasis

United States100 participantsStarted 2022-09-01

Plain-language summary

To compare intraoperative as well as postoperative outcomes of SOLTIVE Thulium laser compared to Ho:YAG laser for the treatment of urolithiasis. The hypothesis is that utilizing the SOLTIVE Thulium laser for the treatment of urolithiasis will result in a more efficient procedure, with comparable stone free rate to that of Holmium laser and subjective improvement in physician satisfaction.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients must be 18 years of age or older
✓. Patients must be diagnosed with single stone burden \<2.0 cm
✓. Patients must opt for definitive treatment with ureteroscopy with lase lithotripsy and stone basket extraction

Exclusion criteria

✕. Patients with multiple stones or stones bilaterally
✕. Patient with stones \>2.0cm
✕. Patient who wish to continue with trial of passage

What they're measuring

To evaluate the stone free rate of patients undergoing ureteroscopy with laser lithotripsy for urolithiasis at first follow up visit

Timeframe: 6 months

Trial details

NCT IDNCT04997668

SponsorUniversity of Kansas Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-26

View on ClinicalTrials.gov More Kidney Stone trials